About Swiss Medendi

Vascular damage

Vascular damage induced by ions and cytotoxic drugs are frequent events and known as chemical phlebitis

  • Loss of endothelial cells
  • Inflammatory cells infiltration
  • Edema
  • Thrombosis
  • Sclerosis

Injuries can be proximal or distal to the catheter tips and usually irritates the venous endothelial cells over a longer distance from the catheter tip.

Unique Methods and Technology

Swiss Medendi owns unique technology able to protect patients’ veins from vesicant agents causing irreversible endothelial damages, saving lives, reducing risks and injuries offering enormous cost saving.

Devices

All our devices are disposable and of class IIa. Those do not vary therapeutics administration protocols, infusion speed or drug concentration.
Employing the technology will help hospitals to manage costs, enable doctors to focus more on their patients’ needs, and improve patients’ quality of life.

Intellectual Property

Patents Granted.

LATEST NEWS

CE mark

The device received the CE mark and has been registered with the “Repertorio dei Dispositivi M...

Patent granted for Japan

Tokyo, Japan (October 5, 2015) Swiss Medendi’s patent has been granted by the Japan Patent Office. T...